5-Aminosalicylic acid as enemas or suppositories in distal ulcerative colitis? 1988

M Campieri, and P Gionchetti, and A Belluzzi, and C Brignola, and G M Tabanelli, and M Miglioli, and L Barbara
Istituto di Clinica Medica e Gastroenterologia, Universitá di Bologna, Policlinico S. Orsola, Italy.

Thirty-nine patients with documented active distal proctitis (less than 20 cm) received either 5-aminosalicylic acid (5-ASA) enemas (2 g in 100 ml) or suppositories 1 g b.i.d., in a controlled study. Twenty patients received enemas, while 19 patients received suppositories, for 30 days. No difference could be observed in terms of efficacy; however, it was the patients' opinion that treatment with suppositories was easier than that with enemas (p less than 0.01).

UI MeSH Term Description Entries
D003093 Colitis, Ulcerative Inflammation of the COLON that is predominantly confined to the MUCOSA. Its major symptoms include DIARRHEA, rectal BLEEDING, the passage of MUCUS, and ABDOMINAL PAIN. Colitis Gravis,Idiopathic Proctocolitis,Inflammatory Bowel Disease, Ulcerative Colitis Type,Ulcerative Colitis
D004733 Enema Insertion of a solution or compound through the RECTUM with the purpose of cleansing the COLON or for diagnostic procedures. Enemata,Enemas,Enematas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000285 Administration, Rectal The insertion of drugs into the rectum, usually for confused or incompetent patients, like children, infants, and the very old or comatose. Anal Drug Administration,Drug Administration, Rectal,Instillation, Rectal,Rectal Drug Administration,Drug Administration, Anal,Rectal Administration,Administration, Anal Drug,Administration, Rectal Drug,Administrations, Anal Drug,Administrations, Rectal,Administrations, Rectal Drug,Anal Drug Administrations,Drug Administrations, Anal,Drug Administrations, Rectal,Instillations, Rectal,Rectal Administrations,Rectal Drug Administrations,Rectal Instillation,Rectal Instillations
D000636 Aminosalicylic Acids A group of 2-hydroxybenzoic acids that can be substituted by amino groups at any of the 3-, 4-, 5-, or 6-positions. Acids, Aminosalicylic
D012646 Self Administration Administration of a drug or chemical by the individual under the direction of a physician. It includes administration clinically or experimentally, by human or animal. Administration, Self,Administrations, Self,Self Administrations
D013488 Suppositories Medicated dosage forms that are designed to be inserted into the rectal, vaginal, or urethral orifice of the body for absorption. Generally, the active ingredients are packaged in dosage forms containing fatty bases such as cocoa butter, hydrogenated oil, or glycerogelatin that are solid at room temperature but melt or dissolve at body temperature. Rectal Suppositories,Vaginal Suppositories,Vaginal Suppository,Suppositories, Rectal,Suppositories, Vaginal,Suppository, Vaginal
D019804 Mesalamine An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed) 5-Aminosalicylate,Mesalazine,5-Aminosalicylic Acid,Asacol,Asacolon,Ascolitin,Canasa,Claversal,Fivasa,Lixacol,Mesalamine Hydrochloride,Mesalamine Monosodium Salt,Mesasal,Novo-5 ASA,Pentasa,Rowasa,Salofalk,m-Aminosalicylic Acid,meta-Aminosalicylic Acid,5 Aminosalicylate,5 Aminosalicylic Acid,Hydrochloride, Mesalamine,Monosodium Salt, Mesalamine,Novo 5 ASA,m Aminosalicylic Acid,meta Aminosalicylic Acid

Related Publications

M Campieri, and P Gionchetti, and A Belluzzi, and C Brignola, and G M Tabanelli, and M Miglioli, and L Barbara
December 1988, Gastroenterology,
M Campieri, and P Gionchetti, and A Belluzzi, and C Brignola, and G M Tabanelli, and M Miglioli, and L Barbara
August 1987, The American journal of gastroenterology,
M Campieri, and P Gionchetti, and A Belluzzi, and C Brignola, and G M Tabanelli, and M Miglioli, and L Barbara
June 1986, The American journal of gastroenterology,
M Campieri, and P Gionchetti, and A Belluzzi, and C Brignola, and G M Tabanelli, and M Miglioli, and L Barbara
October 1995, Alimentary pharmacology & therapeutics,
M Campieri, and P Gionchetti, and A Belluzzi, and C Brignola, and G M Tabanelli, and M Miglioli, and L Barbara
December 1987, Digestive diseases and sciences,
M Campieri, and P Gionchetti, and A Belluzzi, and C Brignola, and G M Tabanelli, and M Miglioli, and L Barbara
February 1989, Lancet (London, England),
M Campieri, and P Gionchetti, and A Belluzzi, and C Brignola, and G M Tabanelli, and M Miglioli, and L Barbara
August 1981, Lancet (London, England),
M Campieri, and P Gionchetti, and A Belluzzi, and C Brignola, and G M Tabanelli, and M Miglioli, and L Barbara
May 1993, Gut,
M Campieri, and P Gionchetti, and A Belluzzi, and C Brignola, and G M Tabanelli, and M Miglioli, and L Barbara
June 1985, Missouri medicine,
M Campieri, and P Gionchetti, and A Belluzzi, and C Brignola, and G M Tabanelli, and M Miglioli, and L Barbara
January 1999, Hepato-gastroenterology,
Copied contents to your clipboard!